CBZ trades 9.1% above Wall Street's consensus target of $50.00.
Last 12 months price action with 12-month analyst target path
The base valuation assumes CBZ achieves its forward estimates and maintains a stable P/E multiple of 13.2x. This scenario reflects the blended consensus of 5 Wall Street analysts, balancing both positive catalysts and macroeconomic headwinds over the next 12 months.
As of November 19, 2026, CBIZ, Inc. (CBZ) has a Wall Street consensus price target of $50.00, based on estimates from 5 covering analysts.
Analyst price targets range from a low of $45.00 to a high of $55.00, representing a 20% spread in expectations. The median target of $50.00 aligns closely with the consensus average. The tight target dispersion indicates high conviction among analysts.
The current analyst consensus rating is Hold, with 1 analysts rating the stock as a Buy or Strong Buy,4 rating it Hold, and 0 rating it Sell or Strong Sell. The bearish sentiment suggests caution about the stock at current levels.
From a valuation perspective, CBZ trades at a forward P/E of 13.2x. The forward PEG ratio of 2.46 reflects a premium valuation. Analysts expect EPS to grow +69.0% over the next year.
Our proprietary valuation model, which blends historical multiples with forward estimates, suggests a base-case price target of $72.50, with bear and bull scenarios of $45.68 and $95.53 respectively. Model confidence stands at 43/100, suggesting limited visibility into future performance.
| Company | Market Cap | Price | Target | Upside Potential | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
ESNTEssent Group Ltd. | $5.9B | $64.33 | $70.00 | +8.8% | Buy | 8.6x | 19 |
KFYKorn Ferry | $3.8B | $74.73 | $85.25 | +14.1% | Buy | 14.0x | 11 |
HURNHuron Consulting Group Inc. | $2.7B | $169.60 | $216.50 | +27.7% | Buy | 18.3x | 9 |
FORRForrester Research, Inc. | $173M | $8.92 | — | — | Hold | 11.2x | 4 |
CASSCass Information Systems, Inc. | $703M | $54.59 | $58.50 | +7.2% | Hold | 18.4x | 2 |
BAHBooz Allen Hamilton Holding Corporation | $10.1B | $84.05 | $92.00 | +9.5% | Buy | 13.8x | 23 |
VRSKVerisk Analytics, Inc. | $26.3B | $202.31 | $222.86 | +10.2% | Hold | 26.3x | 25 |
RHIRobert Half Inc. | $4.2B | $40.88 | $41.80 | +2.3% | Hold | 31.3x | 25 |
MMSMaximus, Inc. | $3.4B | $65.26 | $110.00 | +68.6% | Buy | 8.1x | 16 |
EFOREverforth, Inc. | $1.3B | $32.30 | $46.00 | +42.4% | Hold | 8.9x | 13 |
Quick answers to the most common questions about buying CBZ stock.
Wall Street's consensus price target for CBZ is $50, -9.1% from its current price of $N/A. The below-market target from 5 analysts suggests limited near-term appreciation.
CBZ has a consensus rating of "Hold" based on 5 Wall Street analysts. The rating breakdown is mixed, with 4 Hold ratings making up the largest segment. The consensus 12-month price target of $50 implies -9.1% downside from current levels.
With a forward P/E of 13.1847x, CBZ trades at a relatively low valuation. The consensus target of $50 implies -9.1% move, suggesting the market may be pricing in risks.
The most bullish Wall Street analyst has a price target of $55 for CBZ, while the most conservative target is $45. The consensus of $50 represents the median expectation. Our quantitative valuation model projects a bull case target of $96 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.
CBZ is moderately covered, with 5 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 1 have Buy ratings, 4 recommend Hold, and 0 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month CBZ stock forecast based on 5 Wall Street analysts shows a consensus price target of $50, with estimates ranging from $45 (bear case) to $55 (bull case). The median consensus rating is "Hold". Our proprietary valuation model produces a base case fair value of $73, with bear/bull scenarios of $46/$96.
Our quantitative valuation model calculates CBZ's fair value at $73 (base case), with a bear case of $46 and bull case of $96. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 43/100.
CBZ trades at a forward P/E ratio of 13.2x based on next-twelve-months earnings estimates. The higher forward P/E suggests near-term earnings pressure. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
Analysts are cautious on CBZ, with 0 Sell ratings and a price target of $50 (-9.1% from current price). The "Hold" consensus suggests careful evaluation before buying. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
CBZ analyst price targets range from $45 to $55, a 20% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $50 consensus represents the middle ground. Our model's $46-$96 range provides an independent fundamental perspective.
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.